Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

US support for waiving COVID-19 vaccine patent rights puts pressure on drugmakers – but what would a waiver actually look like?

By Dalindyebo Shabalala, Associate Professor, University of Dayton
Share this article
The process will take months, if it's even approved. But just the threat of waiving intellectual property rights could spur faster action.

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter